effective of mindfulness and ACT on inflammatory bowel disease

Comparing the Effectiveness of Mindfulness Based Stress Reduction and Acceptance and Commitment Therapy on Physiological and Psychological Symptoms in Inflammatory Bowel Disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190708044156N1

Enrollment

160

Registered

2020-12-23

Start date

2019-06-21

Completion date

Unknown

Last updated

2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory bowel disease. Ulcerative colitis

Interventions

Intervention 1: first Intervention group called "Acceptance and commitment therapy": it includes 8 psychological training sessions in 1.5 hours. each session is included one of these subjects: ACT int

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: inflammatory bowel disease patients who have inactive and under control disease

Exclusion criteria

Exclusion criteria: Patients under 18 years Patients over 65 years pregnant females patients currently attending psychiatric services patients currently receiving antidepressant medication patients who have received steroid medications in the past three months patients who have previously undergone a stress management programme (relaxation techniques, psycho dynamic psychotherapy, cognitive behavioral therapy, hypnosis)

Design outcomes

Primary

Measure	Time frame
Colitis physiological symptoms. Timepoint: before intervention, after intervention and 60 days after intervention. Method of measurement: Partial Mayo Scoring Index Assessment.;Stress. Timepoint: before intervention, after intervention and 60 days after intervention. Method of measurement: Depression, Anxiety and Stress Scale questionnaire (DASS-21).;Anxiety. Timepoint: before intervention, after intervention and 60 days after intervention. Method of measurement: Depression, Anxiety and Stress Scale questionnaire (DASS-21).;Depression. Timepoint: before intervention, after intervention and 60 days after intervention. Method of measurement: Depression, Anxiety and Stress Scale questionnaire (DASS-21).;Quality of life. Timepoint: before intervention, after intervention and 60 days after intervention. Method of measurement: world health quality of life questionnaire (BREF form).;General Health. Timepoint: before intervention, after intervention and 60 days after intervention. Method of measurement: general health questionnaire (GHQ-28).;Pain perception. Timepoint: before intervention, after intervention and 60 days after intervention. Method of measurement: Mcgill pain perception questionnaire.	—

Measure

Time frame

Colitis physiological symptoms. Timepoint: before intervention, after intervention and 60 days after intervention. Method of measurement: Partial Mayo Scoring Index Assessment.;Stress. Timepoint: before intervention, after intervention and 60 days after intervention. Method of measurement: Depression, Anxiety and Stress Scale questionnaire (DASS-21).;Anxiety. Timepoint: before intervention, after intervention and 60 days after intervention. Method of measurement: Depression, Anxiety and Stress Scale questionnaire (DASS-21).;Depression. Timepoint: before intervention, after intervention and 60 days after intervention. Method of measurement: Depression, Anxiety and Stress Scale questionnaire (DASS-21).;Quality of life. Timepoint: before intervention, after intervention and 60 days after intervention. Method of measurement: world health quality of life questionnaire (BREF form).;General Health. Timepoint: before intervention, after intervention and 60 days after intervention. Method of measurement: general health questionnaire (GHQ-28).;Pain perception. Timepoint: before intervention, after intervention and 60 days after intervention. Method of measurement: Mcgill pain perception questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFateme Sheikh-ali Saghaie

Bahonar University of Kerman, Iran

fateme.saghaie@gmail.com+98 34 3281 9168

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026